Topical pharmaceutical formulation
US8541470B2 · kind B2 · utility
9Cited by
0References
21Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 15, 2008 |
| Grant date | Sep 24, 2013 |
| Priority date | — |
| Expiry date | Aug 1, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A composition for topical application of an NSAID comprises a solution or suspension of the NSAID in a carrier system comprising a polyhydric alcohol, a glycol ether and an ester of A higher fatty acid, the carrier system being present as a single phase at ambient temperatures. The NSAID may be diclofenac as diclofenac acid. The polyhydric alcohol may be a glycol such as isopropylene glycol and the glycol ether may be a diethylene glycol ether such as diethylene glycol monoethyl ether.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.